Research supports reducing the intensity of cancer treatment, and barriers can prevent members of the LGBTQ+ community from receiving cancer screening and care.

by Thomas Celona

Young adults often ignore telltale signs of colorectal cancer, and more evidence supports active surveillance for low-risk prostate cancer.

by Marci A. Landsmann

New immunotherapy approved for small cell lung cancer, and researchers investigate using urine tests to detect cancer.

by Kevin McLaughlin

Disparities in cancer outcomes shrink but persist, and FDA approval increases access to HPV screening.

by Eric Fitzsimmons

People may be able to wait longer between colonoscopies, and a trial evaluates a less invasive option for treating prostate cancer.

by Thomas Celona

Updated recommendation lowers age for breast cancer screening, and laboratory tests will undergo greater FDA oversight.

by Marci A. Landsmann

Supplemental breast screenings are not covered by Medicare, and researchers develop a treatment option for a form of eye cancer.

by Kevin McLaughlin

A urine test may help grade prostate cancers without biopsies, and states look for savings and better health in palliative care.

by Eric Fitzsimmons

Study finds younger generations are aging faster, putting them at increased risk for cancer, and swapping the order of breast cancer treatments could improve patient care.

by Thomas Celona

More cancer patients are enrolling in clinical trials, and sentinel node biopsies alone may be adequate for some early-stage breast cancers.

by Marci A. Landsmann